Deals
Bored by Golf and Cancer Cured, AbbVie CEO Came Back to Work
This article is for subscribers only.
The man writing a $21 billion check to buy cancer drugmaker Pharmacyclics Inc. ended up at the helm of AbbVie Inc. in part because of a bad golf game.
Rick Gonzalez, the 61-year-old chief executive officer of AbbVie, retired from his role as chief operating officer of former parent company Abbott Laboratories in 2007 after a throat cancer diagnosis. There was more to life than work, he decided.